17-a-OH-progesterone to testosterone plasma ratios and their modification after HCG in normal men and in patients with idiopathic infertility. 1988

G Abbaticchio, and G M Nardelli, and M DeFini, and O Nacucchi, and F Brescia, and R Cospite, and G Santoro, and R Giorgino
Department of Internal Medicine, University of Bari, Italy.

We have investigated on eventual relationships existing in men between plasma levels of 17-a-OH-Progesterone (17-a-OH-P) and, plasma levels of Testosterone (T) and on the modifications of these relationships after stimulation of the testicles by HCG (Human Chorionic Gonadotropin). An inverse correlation exists between basal plasma levels of the two steroids and their delta max (%max increase 96 h after the injection of 5000 I.U. of hCG): r = -06, p 0.01. This suggests that the enzymatic steps of the delta -4 steroidogenic pathway are rate-limiting for the synthesis of T. The delta max of the two-steroids are also inversely correlated with the circulating levels of LH (Luteinizing Hormone) (r = -05, -06; p less than 0.01) suggesting that the rate-limiting activity of the delta 4 pathway is under endogenous LH control. A desensitized state of this pathway can be expected in presence of high circulating levels of LH. Similarly to LH also the FSH plasma levels, an index of function of the seminiferous tubules, are inversely correlated with the 17-a-OH-P and T delta max (r = -0.4, -05; p 0.005) indicating close relationships between tubular and interstitial functions. In men with idiopathic oligozoospermia and high circulating levels of FSH we have found increased 17-a-OH-P/T ratios after hCG.

UI MeSH Term Description Entries
D007248 Infertility, Male The inability of the male to effect FERTILIZATION of an OVUM after a specified period of unprotected intercourse. Male sterility is permanent infertility. Sterility, Male,Sub-Fertility, Male,Subfertility, Male,Male Infertility,Male Sterility,Male Sub-Fertility,Male Subfertility,Sub Fertility, Male
D007713 Klinefelter Syndrome A form of male HYPOGONADISM, characterized by the presence of an extra X CHROMOSOME, small TESTES, seminiferous tubule dysgenesis, elevated levels of GONADOTROPINS, low serum TESTOSTERONE, underdeveloped secondary sex characteristics, and male infertility (INFERTILITY, MALE). Patients tend to have long legs and a slim, tall stature. GYNECOMASTIA is present in many of the patients. The classic form has the karyotype 47,XXY. Several karyotype variants include 48,XXYY; 48,XXXY; 49,XXXXY, and mosaic patterns ( 46,XY/47,XXY; 47,XXY/48,XXXY, etc.). 48,XXYY Syndrome,49,XXXXY Syndrome,Klinefelter Syndrome, Variants,Klinefelter's Syndrome,XXXY Males,XXY Syndrome,XXY Trisomy,Xxyy Syndrome,Klinefelter Syndromes,Klinefelter Syndromes, Variants,Klinefelters Syndrome,Syndrome, Klinefelter,Syndrome, Klinefelter's,Syndrome, Variants Klinefelter,Syndrome, XXY,Syndrome, Xxyy,Syndromes, Klinefelter,Syndromes, Variants Klinefelter,Syndromes, XXY,Syndromes, Xxyy,Trisomies, XXY,Trisomy, XXY,XXXY Male,XXY Syndromes,XXY Trisomies,Xxyy Syndromes
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008297 Male Males
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006908 Hydroxyprogesterones Metabolites or derivatives of PROGESTERONE with hydroxyl group substitution at various sites.
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone
D019326 17-alpha-Hydroxyprogesterone A metabolite of PROGESTERONE with a hydroxyl group at the 17-alpha position. It serves as an intermediate in the biosynthesis of HYDROCORTISONE and GONADAL STEROID HORMONES. 17-Hydroxyprogesterone,17 alpha-Hydroxyprogesterone,17-Hydroxyprogesterone, (17 alpha)-Isomer,17-Hydroxyprogesterone, (9 beta, 10 alpha)-Isomer,17 Hydroxyprogesterone,17 alpha Hydroxyprogesterone

Related Publications

G Abbaticchio, and G M Nardelli, and M DeFini, and O Nacucchi, and F Brescia, and R Cospite, and G Santoro, and R Giorgino
February 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
G Abbaticchio, and G M Nardelli, and M DeFini, and O Nacucchi, and F Brescia, and R Cospite, and G Santoro, and R Giorgino
March 1983, Acta endocrinologica,
G Abbaticchio, and G M Nardelli, and M DeFini, and O Nacucchi, and F Brescia, and R Cospite, and G Santoro, and R Giorgino
August 1994, International journal of andrology,
G Abbaticchio, and G M Nardelli, and M DeFini, and O Nacucchi, and F Brescia, and R Cospite, and G Santoro, and R Giorgino
September 1980, Acta endocrinologica,
G Abbaticchio, and G M Nardelli, and M DeFini, and O Nacucchi, and F Brescia, and R Cospite, and G Santoro, and R Giorgino
February 1977, Endokrinologie,
G Abbaticchio, and G M Nardelli, and M DeFini, and O Nacucchi, and F Brescia, and R Cospite, and G Santoro, and R Giorgino
March 1984, Revista clinica espanola,
G Abbaticchio, and G M Nardelli, and M DeFini, and O Nacucchi, and F Brescia, and R Cospite, and G Santoro, and R Giorgino
May 1986, Journal of steroid biochemistry,
G Abbaticchio, and G M Nardelli, and M DeFini, and O Nacucchi, and F Brescia, and R Cospite, and G Santoro, and R Giorgino
January 1979, International journal of fertility,
G Abbaticchio, and G M Nardelli, and M DeFini, and O Nacucchi, and F Brescia, and R Cospite, and G Santoro, and R Giorgino
January 1987, Acta Europaea fertilitatis,
G Abbaticchio, and G M Nardelli, and M DeFini, and O Nacucchi, and F Brescia, and R Cospite, and G Santoro, and R Giorgino
May 1969, The Journal of clinical investigation,
Copied contents to your clipboard!